Stock Market – HedgeChatter

Several Biotech Stocks Indicating A Macro Short Strategy | Seeking …

SummaryOvaScience, Sarpeta Therapeutics, Ziopharm Oncology and Keryx Biopharmaceuticals all have a short interest above 20%.
These small cap biotech companies provide attractive characteristics for fundamental weakness through liquidity needs, no revenue and a higher fail rate.
Given these common variables, there is strong indication that a large Marco short strategy has been put in place.
This large short position provides opportunities for contrarian […]

July 2, 2015 BySeekingAlpha.com biopharmaceuticals, biotech, chinese, greek, keryx, keryx-biopharmaceuticals, king, OVAS, sarpeta, therapeutics, union Comments Off read more

Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal …

The Celgene Corporation (CELG – Analyst Report) – Juno Therapeutics’ (JUNO – Analyst Report) immunotherapy deal worth at least a billion dollars was the main story in the biotech sector this week. While concerns are being raised about the high price tag, the deal just goes to show the growing interest in the field of immunotherapy. Meanwhile, quite a few […]

July 1, 2015 ByArpita Dutt analyst, analyst-report, celgene, europe, gene, investment, major, nasdaq, report Comments Off read more

Biotech Stock News (EPZM) (VICL) (ALPMF) (CBLI) | CNA Finance

Epizyme (NASDAQ:EPZM)On June 22, 2015 shares of Epizyme were up about 27% after the company announced that it had obtained positive phase 1 results in patients with Non-Hodgkin’s Lymphoma — NHL. The company used its drug known as EPZ-6438, which is also known as tazemetostat to treat these patients with NHL. Epizyme has developed this drug to treat these NHL […]

June 30, 2015 ByTerry Chrisomalis biotech, biotech-stock, company, curaxin, epizyme, herpes, international, nasdaq, nhl, stock, vical Comments Off read more

Biotech Stock News (AAVL) (AERI) (AGN) (KYTH) (RHHBY) (REGN …

Avalanche Biotech (NASDAQ:AAVL)Shares of Avalanche Biotech fell as much as 40% in after-hours trading on June 15, 2015 after the company announced results from its phase 2 wet-age related macular degeneration — wet-AMD — trial. The drop is huge but many investors should be assured that the drop was justified because the results were mediocre at best. In addition if […]

June 23, 2015 ByTerry Chrisomalis AMGN, biotech, biotech-stock, eylea, historical, kythera, nasdaq, pharmaceuticals, regeneron, stock Comments Off read more

Finding The Next Blockbuster Biotech Stock – ETF Daily News

Kyle Anderson: Spending on cancer treatment has been skyrocketing globally. According to the IMS Institute of Health, spending on cancer topped $100 billion globally in 2014. That was a 10% increase from 2013.That’s why many biotech stocks tied to cancer treatments have seen triple-digit gains in the last two years.Have you ever wondered how billionaires continue to get RICHER, while the rest of […]

June 23, 2015 ByDavid Bettencourt biotech-stock, biotechnology, black, company, health, investing, news, process, protein, therapeutics, world Comments Off read more

These Promising Cancer Therapies Are a Biotech Stocks "Triple Play"

These Promising Cancer Therapies Are a Biotech Stocks “Triple Play”Companies / BioTechJun 19, 2015 – 03:04 PM GMTBy: Money_MorningErnie Tremblay writes: On Jan. 7, 2015, CytRX Corp. (NASDAQ: CYTR) announced positive results from a study of its experimental brain cancer drug, aldoxorubicin, and the company’s stock immediately jumped 15.8%. Then, over the next four months, it nearly doubled.Over the months […]

June 19, 2015 Byunknown bellicum, cancer, CAR, company, money, pennsylvania, publishing, street, university Comments Off read more

Cramer: Secret pattern to unlocking biotech riches – CNBC.com

Biotech gains attainable?
Mad Money’s Jim Cramer picked up on a biotech pattern that could benefit your portfolio.
Jim Cramer has picked up on a pattern when it comes to biotech stocks that could change the game for an investor’s portfolio—listen to the darned CEO interviews.In fact, Cramer would argue that the biotech group has gone from being hit or miss to […]

June 18, 2015 Byunknown allergan, ceo, cramer, facebook, science, stock, study, twitter Comments Off read more

Capitalize on Comeback Stories in Micro-Cap Biotech Stocks :: The …

Capitalize on Comeback Stories in Micro-Cap Biotech StocksCompanies / BioTechJun 17, 2015 – 09:55 PM GMTBy: TLSReportThe list of problems with investing in micro-cap biotech stocks begins with extreme volatility and lack of liquidity and ends with the inability to get validation from sophisticated investors who are unable to own such small companies. Nevertheless, sift through the pile and investors […]

June 17, 2015 Byunknown aml, celator, drug, fda, interview, major, pantginis, report, reports, rexahn, sciences, sunesis Comments Off read more

Five Biotech Stocks for the Next Six Months – Stocks to Watch …

By Ben LevisohnSunTrust Robinson Humphrey’s Edward Nash and team offer five biotech stocks for the next six months:
Cempra (CEMP) ($50 PT), our top pick based on near-term clinical and commercial success potential. We recently met with management and it was reiterated that the second Phase III study of solithromycin in CABP (SOLITAIRE-IV) remains on track to report top-line data by […]

June 17, 2015 ByBen Levisohn agency, cellular, iii, major, management, sarepta, sarepta-therapeutics, therapies Comments Off read more

Best Investor Play in the Hottest Biotech Stock Market on Earth :: The …

Best Investor Play in the Hottest Biotech Stock Market on EarthCompanies / Tech StocksJun 17, 2015 – 08:01 AM GMTBy: Money_MorningMichael A. Robinson writes: Biotechnology is a big opportunity. And China is a big market.Combine the two and you have a big potential for investment profits.In today’s Strategic Tech Investor, I’m talking with Money Map Press Executive Editor William Patalon […]

June 17, 2015 Byunknown baltimore, biologic, china, money, private, products, stock, united Comments Off on Best Investor Play in the Hottest Biotech Stock Market on Earth :: The … read more